Table of Contents Author Guidelines Submit a Manuscript
Mediators of Inflammation
Volume 2010, Article ID 367838, 8 pages
http://dx.doi.org/10.1155/2010/367838
Review Article

Functional Food Targeting the Regulation of Obesity-Induced Inflammatory Responses and Pathologies

1Laboratory of Molecular Function of Food, Division of Food Science and Biotechnology, Graduate School of Agriculture, Kyoto University, Uji, Kyoto 611-0011, Japan
2Department of Food Science and Nutrition, University of Ulsan, Ulsan 680-749, Republic of Korea

Received 9 December 2009; Accepted 8 March 2010

Academic Editor: Oreste Gualillo

Copyright © 2010 Shizuka Hirai et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. G. S. Hotamisligil, N. S. Shargill, and B. M. Spiegelman, “Adipose expression of tumor necrosis factor-α: direct role in obesity-linked insulin resistance,” Science, vol. 259, no. 5091, pp. 87–91, 1993. View at Google Scholar · View at Scopus
  2. S. P. Weisberg, D. McCann, M. Desai, M. Rosenbaum, R. L. Leibel, and A. W. Ferrante Jr., “Obesity is associated with macrophage accumulation in adipose tissue,” The Journal of Clinical Investigation, vol. 112, no. 12, pp. 1796–1808, 2003. View at Google Scholar
  3. H. Xu, G. T. Barnes, Q. Yang et al., “Chronic inflammation in fat plays a crucial role in the development of obesity-related insulin resistance,” Journal of Clinical Investigation, vol. 112, no. 12, pp. 1821–1830, 2003. View at Publisher · View at Google Scholar · View at Scopus
  4. T. P. Markovic and S. J. Natoli, “Paradoxical nutritional deficiency in overweight and obesity: the importance of nutrient density,” The Medical Journal of Australia, vol. 190, no. 3, pp. 149–151, 2009. View at Google Scholar · View at Scopus
  5. M. C. Arkan, A. L. Hevener, F. R. Greten et al., “IKK-ß links inflammation to obesity-induced insulin resistance,” Nature Medicine, vol. 11, no. 2, pp. 191–198, 2005. View at Google Scholar
  6. G. Solinas, C. Vilcu, J. G. Neels et al., “JNK1 in hematopoietically derived cells contributes to diet-induced inflammation and insulin resistance without affecting obesity,” Cell Metabolism, vol. 6, no. 5, pp. 386–397, 2007. View at Publisher · View at Google Scholar · View at Scopus
  7. M. Ricote, A. C. Li, T. M. Willson, C. J. Kelly, and C. K. Glass, “The peroxisome proliferator-activated receptor-γ is a negative regulator of macrophage activation,” Nature, vol. 391, no. 6662, pp. 79–82, 1998. View at Publisher · View at Google Scholar · View at Scopus
  8. J. N. Fain, A. K. Madan, M. L. Hiler, P. Cheema, and S. W. Bahouth, “Comparison of the release of adipokines by adipose tissue, adipose tissue matrix, and adipocytes from visceral and subcutaneous abdominal adipose tissues of obese humans,” Endocrinology, vol. 145, no. 5, pp. 2273–2282, 2004. View at Publisher · View at Google Scholar · View at Scopus
  9. J. M. Bruun, A. S. Lihn, S. B. Pedersen, and B. Richelsen, “Monocyte chemoattractant protein-1 release is higher in visceral than subcutaneous human adipose tissue (AT): implication of macrophages resident in the AT,” The Journal of Clinical Endocrinology and Metabolism, vol. 90, no. 4, pp. 2282–2289, 2005. View at Google Scholar
  10. R. Yu, C.-S. Kim, B.-S. Kwon, and T. Kawada, “Mesenteric adipose tissue-derived monocyte chemoattractant protein-1 plays a crucial role in adipose tissue macrophage migration and activation in obese mice,” Obesity, vol. 14, no. 8, pp. 1353–1362, 2006. View at Publisher · View at Google Scholar · View at Scopus
  11. T. Suganami, J. Nishida, and Y. Ogawa, “A paracrine loop between adipocytes and macrophages aggravates inflammatory changes: role of free fatty acids and tumor necrosis factor α,” Arteriosclerosis, Thrombosis, and Vascular Biology, vol. 25, no. 10, pp. 2062–2068, 2005. View at Publisher · View at Google Scholar · View at Scopus
  12. S. Hirai, Y.-I. Kim, T. Goto et al., “Inhibitory effect of naringenin chalcone on inflammatory changes in the interaction between adipocytes and macrophages,” Life Sciences, vol. 81, no. 16, pp. 1272–1279, 2007. View at Publisher · View at Google Scholar · View at Scopus
  13. G. Boden, “Role of fatty acids in the pathogenesis of insulin resistance and NIDDM,” Diabetes, vol. 46, no. 1, pp. 3–10, 1997. View at Google Scholar · View at Scopus
  14. J. Y. Lee, K. H. Sohn, S. H. Rhee, and D. Hwang, “Saturated fatty acids, but not unsaturated fatty acids, induce the expression of cyclooxygenase-2 mediated through toll-like receptor 4,” The Journal of Biological Chemistry, vol. 276, no. 20, pp. 16683–16689, 2001. View at Publisher · View at Google Scholar · View at Scopus
  15. T. Suganami, K. Tanimoto-Koyama, J. Nishida et al., “Role of the toll-like receptor 4/NF-?B pathway in saturated fatty acid-induced inflammatory changes in the interaction between adipocytes and macrophages,” Arteriosclerosis, Thrombosis, and Vascular Biology, vol. 27, no. 1, pp. 84–91, 2007. View at Publisher · View at Google Scholar · View at Scopus
  16. H. Shi, M. V. Kokoeva, K. Inouye, I. Tzameli, H. Yin, and J. S. Flier, “TLR4 links innate immunity and fatty acid-induced insulin resistance,” Journal of Clinical Investigation, vol. 116, no. 11, pp. 3015–3025, 2006. View at Publisher · View at Google Scholar · View at Scopus
  17. C. Ando, N. Takahashi, S. Hirai et al., “Luteolin, a food-derived flavonoid, suppresses adipocyte-dependent activation of macrophages by inhibiting JNK activation,” FEBS Letters, vol. 583, no. 22, pp. 3649–3654, 2009. View at Publisher · View at Google Scholar · View at Scopus
  18. G. Chinetti, J.-C. Fruchart, and B. Staels, “Peroxisome proliferator-activated receptors (PPARs): nuclear receptors at the crossroads between lipid metabolism and inflammation,” Inflammation Research, vol. 49, no. 10, pp. 497–505, 2000. View at Publisher · View at Google Scholar · View at Scopus
  19. C. K. Glass, “Potential roles of the peroxisome proliferator-activated receptor-γ in macrophage biology and atherosclerosis,” Journal of Endocrinology, vol. 169, no. 3, pp. 461–464, 2001. View at Publisher · View at Google Scholar · View at Scopus
  20. K. J. Moore, E. D. Rosen, M. L. Fitzgerald et al., “The role of PPAR-? in macrophage differentiation and cholesterol uptake,” Nature Medicine, vol. 7, no. 1, pp. 41–47, 2001. View at Publisher · View at Google Scholar · View at Scopus
  21. B. M. Spiegelman, “Peroxisome proliferator-activated receptor γ: a key regulator of adipogenesis and systemic insulin sensitivity,” European Journal of Medical Research, vol. 2, no. 11, pp. 457–464, 1997. View at Google Scholar
  22. N. Maeda, I. Shimomura, K. Kishida et al., “Diet-induced insulin resistance in mice lacking adiponectin/ACRP30,” Nature Medicine, vol. 8, no. 7, pp. 731–737, 2002. View at Publisher · View at Google Scholar · View at Scopus
  23. T. Yamauchi, J. Kamon, H. Waki et al., “The mechanisms by which both heterozygous peroxisome proliferator-activated receptor ? (PPAR?) deficiency and PPAR? agonist improve insulin resistance,” The Journal of Biological Chemistry, vol. 276, no. 44, pp. 41245–41254, 2001. View at Google Scholar
  24. G. Pascual, A. L. Fong, S. Ogawa et al., “A SUMOylation-dependent pathway mediates transrepression of inflammatory response genes by PPAR-?,” Nature, vol. 437, no. 7059, pp. 759–763, 2005. View at Publisher · View at Google Scholar · View at Scopus
  25. N. Takahashi, T. Kawada, T. Goto et al., “Dual action of isoprenols from herbal medicines on both PPAR? and PPARa in 3T3-L1 adipocytes and HepG2 hepatocytes,” FEBS Letters, vol. 514, no. 2-3, pp. 315–322, 2002. View at Publisher · View at Google Scholar · View at Scopus
  26. T. Kawada, T. Watanabe, and T. Takaishi, “Capsaicin-induced β-adrenergic action on energy metabolism in rats: influence of capsaicin on oxygen consumption, the respiratory quotient, and substrate utilization,” Proceedings of the Society for Experimental Biology and Medicine, vol. 183, no. 2, pp. 250–256, 1986. View at Google Scholar
  27. Y.-J. Surh, “Anti-tumor promoting potential of selected spice ingredients with antioxidative and anti-inflammatory activities: a short review,” Food and Chemical Toxicology, vol. 40, no. 8, pp. 1091–1097, 2002. View at Publisher · View at Google Scholar · View at Scopus
  28. M. Westerterp-Plantenga, K. Diepvens, A. M. C. P. Joosen, S. Bérubé-Parent, and A. Tremblay, “Metabolic effects of spices, teas, and caffeine,” Physiology & Behavior, vol. 89, no. 1, pp. 85–91, 2006. View at Publisher · View at Google Scholar · View at Scopus
  29. J.-H. Kang, C.-S. Kim, I.-S. Han, T. Kawada, and R. Yu, “Capsaicin, a spicy component of hot peppers, modulates adipokine gene expression and protein release from obese-mouse adipose tissues and isolated adipocytes, and suppresses the inflammatory responses of adipose tissue macrophages,” FEBS Letters, vol. 581, no. 23, pp. 4389–4396, 2007. View at Publisher · View at Google Scholar · View at Scopus
  30. H.-M. Woo, J.-H. Kang, T. Kawada, H. Yoo, M.-K. Sung, and R. Yu, “Active spice-derived components can inhibit inflammatory responses of adipose tissue in obesity by suppressing inflammatory actions of macrophages and release of monocyte chemoattractant protein-1 from adipocytes,” Life Sciences, vol. 80, no. 10, pp. 926–931, 2007. View at Publisher · View at Google Scholar · View at Scopus
  31. C.-S. Kim, T. Kawada, B.-S. Kim et al., “Capsaicin exhibits anti-inflammatory property by inhibiting IkB-a degradation in LPS-stimulated peritoneal macrophages,” Cellular Signalling, vol. 15, no. 3, pp. 299–306, 2003. View at Publisher · View at Google Scholar · View at Scopus
  32. A. S. A. Levy, O. Simon, J. Shelly, and M. Gardener, “6-Shogaol reduced chronic inflammatory response in the knees of rats treated with complete Freund's adjuvant,” BMC Pharmacology, vol. 6, article 12, 2006. View at Publisher · View at Google Scholar · View at Scopus
  33. J. A. Ojewole, “Analgesic, antiinflammatory and hypoglycaemic effects of ethanol extract of Zingiber officinale (Roscoe) rhizomes (Zingiberaceae) in mice and rats,” Phytotherapy Research, vol. 20, no. 9, pp. 764–772, 2006. View at Google Scholar
  34. Y. Isa, Y. Miyakawa, M. Yanagisawa et al., “6-Shogaol and 6-gingerol, the pungent of ginger, inhibit TNF-a mediated downregulation of adiponectin expression via different mechanisms in 3T3-L1 adipocytes,” Biochemical and Biophysical Research Communications, vol. 373, no. 3, pp. 429–434, 2008. View at Publisher · View at Google Scholar · View at Scopus
  35. C. E. Elson, G. L. Underbakke, P. Hanson, E. Shrago, R. H. Wainberg, and A. A. Qureshi, “Impact of lemongrass oil, an essential oil, on serum cholesterol,” Lipids, vol. 24, no. 8, pp. 677–679, 1989. View at Google Scholar · View at Scopus
  36. L. He, H. Mo, S. Hadisusilo, A. A. Qureshi, and C. E. Elson, “Isoprenoids suppress the growth of murine B16 melanomas in vitro and in vivo,” Journal of Nutrition, vol. 127, no. 5, pp. 668–674, 1997. View at Google Scholar · View at Scopus
  37. A. L. Miller, “Dimercaptosuccinic acid (DMSA), a non-toxic, water-soluble treatment for heavy metal toxicity,” Alternative Medicine Review, vol. 3, no. 3, pp. 199–207, 1998. View at Google Scholar · View at Scopus
  38. F. J. Aranda and J. Villalaín, “The interaction of abietic acid with phospholipid membranes,” Biochimica et Biophysica Acta, vol. 1327, no. 2, pp. 171–180, 1997. View at Publisher · View at Google Scholar · View at Scopus
  39. M.-S. Kang, S. Hirai, T. Goto et al., “Dehdroabietic acid,a diterpene improves diabetes and hyperlipdemia in obese diabitic KK-Ay mice,” BioFactors, vol. 35, no. 5, pp. 442–448, 2009. View at Publisher · View at Google Scholar · View at Scopus
  40. M.-S. Kang, S. Hirai, T. Goto et al., “Dehydroabietic acid, a phytochemical, acts as ligand for PPARs in macrophages and adipocytes to regulate inflammation,” Biochemical and Biophysical Research Communications, vol. 369, no. 2, pp. 333–338, 2008. View at Publisher · View at Google Scholar · View at Scopus
  41. A. Tsuchida, T. Yamauchi, S. Takekawa et al., “Peroxisome proliferator-activated receptor (PPAR)a activation increases adiponectin receptors and reduces obesity-related inflammation in adipose tissue: comparison of activation of PPARa, PPAR?, and their combination,” Diabetes, vol. 54, no. 12, pp. 3358–3370, 2005. View at Google Scholar
  42. K. Kuroyanagi, M.-S. Kang, T. Goto et al., “Citrus auraptene acts as an agonist for PPARs and enhances adiponectin production and MCP-1 reduction in 3T3-L1 adipocytes,” Biochemical and Biophysical Research Communications, vol. 366, no. 1, pp. 219–225, 2008. View at Publisher · View at Google Scholar · View at Scopus
  43. N. Takahashi, M.-S. Kang, K. Kuroyanagi et al., “Auraptene, a citrus fruit compound, regulates gene expression as a PPARa agonist in HepG2 hepatocytes,” BioFactors, vol. 33, no. 1, pp. 25–32, 2008. View at Publisher · View at Google Scholar · View at Scopus
  44. S. Sharma, A. Sowjanya, M. Kumari et al., “Biochemical mechanism of insulin sensitization, lipid modulation and anti-atherogenic potential of PPAR a/? dual agonist: ragaglitazar,” Life Sciences, vol. 80, no. 3, pp. 235–244, 2006. View at Publisher · View at Google Scholar · View at Scopus
  45. E. Middleton Jr., C. Kandaswami, and T. C. Theoharides, “The effects of plant flavonoids on mammalian cells: implications for inflammation, heart disease, and cancer,” Pharmacological Reviews, vol. 52, no. 4, pp. 673–751, 2000. View at Google Scholar · View at Scopus
  46. T. Yamamoto, M. Yoshimura, F. Yamaguchi et al., “Anti-allergic activity of naringenin chalcone from a tomato skin extract,” Bioscience, Biotechnology and Biochemistry, vol. 68, no. 8, pp. 1706–1711, 2004. View at Publisher · View at Google Scholar · View at Scopus
  47. T. Tsuda, F. Horio, K. Uchida, H. Aoki, and T. Osawa, “Dietary cyanidin 3-O-β-D-glucoside-rich purple corn color prevents obesity and ameliorates hyperglycemia in mice,” Journal of Nutrition, vol. 133, no. 7, pp. 2125–2130, 2003. View at Google Scholar · View at Scopus
  48. T. Tsuda, “Regulation of adipocyte function by anthocyanins; possibility of preventing the metabolic syndrome,” Journal of Agricultural and Food Chemistry, vol. 56, no. 3, pp. 642–646, 2008. View at Publisher · View at Google Scholar · View at Scopus
  49. R. Sasaki, N. Nishimura, H. Hoshino et al., “Cyanidin 3-glucoside ameliorates hyperglycemia and insulin sensitivity due to downregulation of retinol binding protein 4 expression in diabetic mice,” Biochemical Pharmacology, vol. 74, no. 11, pp. 1619–1627, 2007. View at Publisher · View at Google Scholar · View at Scopus
  50. Z. Madar, R. Abel, S. Samish, and J. Arad, “Glucose-lowering effect of fenugreek in non-insulin dependent diabetics,” European Journal of Clinical Nutrition, vol. 42, no. 1, pp. 51–54, 1988. View at Google Scholar
  51. G. Valette, Y. Sauvaire, J. C. Baccou, and G. Ribes, “Hypocholesterolaemic effect of fenugreek seeds in dogs,” Atherosclerosis, vol. 50, no. 1, pp. 105–111, 1984. View at Google Scholar · View at Scopus
  52. F.-L. Chiu and J.-K. Lin, “Tomatidine inhibits iNOS and COX-2 through suppression of NF-κB and JNK pathways in LPS-stimulated mouse macrophages,” FEBS Letters, vol. 582, no. 16, pp. 2407–2412, 2008. View at Publisher · View at Google Scholar · View at Scopus
  53. S. Hirai, T. Uemura, N. Mizoguchi et al., “Diosgenin attenuates inflammatory changes in the interaction between adipocytes and macrophages,” Molecular Nutrition and Food Research. In press.
  54. Y. Isa, Y. Miyakawa, M. Yanagisawa et al., “6-Shogaol and 6-gingerol, the pungent of ginger, inhibit TNF-a mediated downregulation of adiponectin expression via different mechanisms in 3T3-L1 adipocytes,” Biochemical and Biophysical Research Communications, vol. 373, no. 3, pp. 429–434, 2008. View at Publisher · View at Google Scholar · View at Scopus
  55. J. Todoric, M. Löffler, J. Huber et al., “Adipose tissue inflammation induced by high-fat diet in obese diabetic mice is prevented by n-3 polyunsaturated fatty acids,” Diabetologia, vol. 49, no. 9, pp. 2109–2119, 2006. View at Publisher · View at Google Scholar · View at Scopus
  56. J. Huber, M. Löffler, M. Bilban et al., “Prevention of high-fat diet-induced adipose tissue remodeling in obese diabetic mice by n-3 polyunsaturated fatty acids,” International Journal of Obesity, vol. 31, no. 6, pp. 1004–1013, 2007. View at Publisher · View at Google Scholar · View at Scopus
  57. T. M. Stulnig, “Immunomodulation by polyunsaturated fatty acids: mechanisms and effects,” International Archives of Allergy and Immunology, vol. 132, no. 4, pp. 310–321, 2003. View at Publisher · View at Google Scholar · View at Scopus
  58. U. N. Das, “Folic acid says NO to vascular diseases,” Nutrition, vol. 19, no. 7-8, pp. 686–692, 2003. View at Publisher · View at Google Scholar · View at Scopus
  59. R. Stienstra, C. Duval, S. Keshtkar, J. Van Der Laak, S. Kersten, and M. Müller, “Peroxisome proliferator-activated receptor γ activation promotes infiltration of alternatively activated macrophages into adipose tissue,” The Journal of Biological Chemistry, vol. 283, no. 33, pp. 22620–22627, 2008. View at Publisher · View at Google Scholar · View at Scopus
  60. S. Kiokias and M. H. Gordon, “Dietary supplementation with a natural carotenoid mixture decreases oxidative stress,” European Journal of Clinical Nutrition, vol. 57, no. 9, pp. 1135–1140, 2003. View at Publisher · View at Google Scholar · View at Scopus